Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Number of holders
59
Total Shares
33.9M
Shares change
-295K
Total reported value, excl. options
$129M
Value change
-$1.3M
Put/Call ratio
0.25
Number of buys
23
Number of sells
-27
Price
$3.81
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.